47.93USD+0.67%Mkt Cap: 2.42B $P/E: 226.711d ago
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to …
Industry Peers
Medical Instruments & SuppliesKey Statistics
Company
Market Cap2.42B $
Enterprise Value2.32B $
Revenue (TTM)569.62M $
Gross Profit400.78M $
Net Income (TTM)-11.45M $
Revenue/Share11.81 USD
Last Price47.93 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.4K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)226.71
P/E (Forward)109.99
PEG10.00
EV/EBITDA68.81
EV/Revenue4.08
P/S4.24
P/B4.68
EPS (TTM)0.21
EPS (Forward)0.43
52W Range
25.37100% of range47.98
52W High47.98 USD
52W Low25.37 USD
Profitability
Gross Margin74.98%
Oper. Margin6.29%
EBITDA Margin5.92%
Profit Margin-2.14%
ROE-2.33%
ROA-1.75%
Growth
Revenue Growth12.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF57.33M $
CapEx (TTM)15.05M $
FCF Margin8.57%
FCF Yield2.02%
Net Debt-93.56M $
Net Debt/EBITDA-2.77
Balance Sheet
Debt/Equity0.15
Current Ratio4.22
Quick Ratio3.02
Book Value/Sh10.15 USD
Cash/Share3.299 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)47.33 USD
Upside (mean)-1.2%
Target Range36.00 USD – 55.00 USD
$36.00-1.2% to mean$55.00
# Analysts9
Ownership
Shares Out.50.87M
Float48.80M
Insiders3.81%
Institutions105.97%
Short Interest
Short Ratio4.0d
Short % Float7.91%
Short % Out.7.60%
Shares Short3.86M
Short (prev mo.)4.45M
Technical
SMA 5035.33 (+35.7%)
SMA 20033.58 (+42.7%)
Beta1.23
S&P 52W Chg18.16%
Avg Vol (30d)824.17K
Avg Vol (10d)660.90K
Technical Indicators
RSI (14)82.1
MACD3.1471
MACD Signal2.7111
MACD Hist.+0.4360
BB Upper47.70 USD
BB Middle40.19 USD
BB Lower32.67 USD
BB Width37.41%
ATR (14)1.796 USD
Vol Ratio (20d)1.06x